Oric Pharmaceuticals, Inc.
ORIC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796280
In the last 90 days, Oric Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; Viking Global Investors is the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding Oric Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 90 | 1 | 92 | +3 |
| Shares | 48.1M | 602.3K | 50.6M | +3.19M (+6.7%) |
| Value | $290.7M | $3.64M | $465.9M | +$178.8M (+62.3%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Janus Henderson Group PLC | 659,054 | $6.07M | 0.00% |
| Point72 Asset Management, L.P. | 521,142 | $4.79M | 0.01% |
| Sphera Funds Management Ltd. | 126,800 | $1.17M | 0.22% |
| Caption Management, LLC | 95,260 | $876.4K | 0.10% |
| TD Asset Management Inc | 80,800 | $743.4K | 0.00% |
| DAFNA Capital Management LLC | 72,797 | $669.7K | 0.16% |
| Wellington Management Group LLP | 72,397 | $666.1K | 0.00% |
| Campbell & CO Investment Adviser LLC | 37,619 | $346.1K | 0.03% |
| Squarepoint Ops LLC | 26,056 | $239.7K | 0.00% |
| Alliancebernstein L.P. | 15,320 | $140.9K | 0.00% |
| Baird Financial Group, Inc. | 12,341 | $113.5K | 0.00% |
| Virtus ETF Advisers LLC | 10,085 | $92.8K | 0.06% |
| LPL Financial LLC | 10,000 | $92.0K | 0.00% |
| STRS Ohio | 7,900 | $72.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 6,305 | $58.0K | 0.01% |
| AJOVista, LLC | 4,357 | $40.1K | 0.05% |
| Fortitude Family Office, LLC | 574 | $5.28K | 0.00% |
| Signaturefd, LLC | 274 | $2.52K | 0.00% |
| Lindbrook Capital, LLC | 214 | $1.97K | 0.00% |
| Simplex Trading, LLC | 163 | $1.00K | 0.00% |
Sold out (17)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Millennium Management LLC | 1,163,760 | $7.04M |
| Octagon Capital Advisors LP | 204,500 | $1.24M |
| Citadel Advisors LLC | 145,007 | $877.3K |
| Pale Fire Capital SE | 33,055 | $200.0K |
| Jump Financial, LLC | 32,149 | $194.5K |
| Verition Fund Management LLC | 24,400 | $147.6K |
| Acadian Asset Management LLC | 22,691 | $137.0K |
| Virtu Financial LLC | 19,461 | $118.0K |
| Dynamic Technology Lab Private Ltd | 15,723 | $95.0K |
| Algert Global LLC | 13,430 | $81.3K |
| Sherbrooke Park Advisers LLC | 11,911 | $72.1K |
| XTX Topco Ltd | 11,320 | $68.5K |
| Allspring Global Investments Holdings, LLC | 3,414 | $20.7K |
| Dorsey Wright & Associates | 2,513 | $15.2K |
| Federated Hermes, Inc. | 624 | $3.77K |
| Russell Investments Group, Ltd. | 28 | $169 |
| Crewe Advisors LLC | 16 | $97 |
Not filed for Q4 2023 yet (1)
Institutions that held Oric Pharmaceuticals, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $3.64M |